Page last updated: 2024-10-19

phytic acid and Multiple Sclerosis

phytic acid has been researched along with Multiple Sclerosis in 1 studies

Phytic Acid: Complexing agent for removal of traces of heavy metal ions. It acts also as a hypocalcemic agent.
myo-inositol hexakisphosphate : A myo-inositol hexakisphosphate in which each hydroxy group of myo-inositol is monophosphorylated.

Multiple Sclerosis: An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies

Other Studies

1 other study available for phytic acid and Multiple Sclerosis

ArticleYear
Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course.
    Cell, 2022, 09-15, Volume: 185, Issue:19

    Topics: Fatty Acids, Volatile; Gastrointestinal Microbiome; Humans; Interferon-beta; Multiple Sclerosis; Phy

2022